WilmerHale Represents Dedrone in Acquisition by Axon

WilmerHale Represents Dedrone in Acquisition by Axon

Client News

On May 6, 2024, Axon, the global public safety technology leader, announced it had entered into a definitive agreement to acquire Dedrone, a global leader in airspace security. Axon's mission to Protect Life finds a powerful ally in Dedrone, whose innovative technologies provide immense value to public safety and national security entities worldwide by protecting against increasing drone threats and advancing the use of Drones as First Responders (DFR). Ultimately, upon completion of the acquisition, Dedrone will strengthen Axon's ability to help customers safeguard their communities, improve response to critical incidents and protect even more lives in more places. The transaction is subject to customary closing conditions and is expected to close in the second half of 2024. The terms of the transaction were not disclosed.

The WilmerHale corporate team advising Dedrone was led by Daniel Zimmermann and Michael Gilligan and included Scott Scharf, Taylor Mielnicki, Shafi Armatis and Ben Goldfein. The WilmerHale team also included Stephen Gillespie and Aron Nimani on intellectual property, technology and licensing matters; Scott Kilgore, Julie Hogan Rodgers, Ciara Baker, Ben Kelsey, Atul Jain and Simona Altshuler on employment, employee benefits, equity compensation and tax matters; Golo Weidmann, Christian Crones and Karsten Silbernagel and on German law issues; and Barry Hurewitz, Cormac O’Daly, Oliver Fleischmann and Hartmut Schneider on regulatory matters, including government contracting, foreign direct investment and antitrust issues, respectively.


Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.